IDEA Collider: Innovation & Asymmetric Learning in Pharma cover image

The Misconceptions In The Pharma Industry With John L. Lamattina

IDEA Collider: Innovation & Asymmetric Learning in Pharma

00:00

Pcsk9

Two companies, Regeneron and Amgen came up with a biological molecule that worked wonders for lowering LDL cholesterol. Lipitor at its peak sold, almost $13 billion a year. The next year it went off patent and that number dropped by 90 some odd percent. And the same thing helped us through here. Then we flip into, I mean, the, you know, you enter into the payers, but this is one of those genuinely interesting marketplaces.

Play episode from 19:09
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app